Daniela Matei Selected Research

Daniela Matei Research Topics

Disease

69	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 01/2004
66	Neoplasms (Cancer) 01/2024 - 09/2006
13	Ovarian Epithelial Carcinoma 01/2019 - 09/2002
7	Endometrial Neoplasms (Endometrial Cancer) 10/2022 - 04/2014
7	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2009
6	Ascites 01/2021 - 08/2007
5	Carcinoma (Carcinomatosis) 08/2022 - 01/2010
4	Hemorrhage 01/2022 - 08/2013
4	Nausea 01/2020 - 09/2009
4	Fatigue 01/2020 - 04/2012
4	Peritoneal Neoplasms 01/2011 - 08/2008
3	Chronic Obstructive Pulmonary Disease (COPD) 08/2023 - 11/2022
3	Disease Progression 01/2019 - 02/2014
3	Glioblastoma (Glioblastoma Multiforme) 12/2014 - 01/2007
2	Carcinogenesis 01/2024 - 11/2021
2	Inflammation (Inflammations) 01/2023 - 01/2022
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2022 - 04/2021
2	Non-alcoholic Fatty Liver Disease 05/2022 - 04/2021
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 12/2014
2	Epilepsy (Aura) 01/2020 - 01/2019
2	Hypertension (High Blood Pressure) 01/2020 - 12/2014
2	Diarrhea 01/2020 - 09/2006
2	Fallopian Tube Neoplasms 01/2018 - 02/2014
2	Thrombocytopenia (Thrombopenia) 01/2018 - 12/2013
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2016 - 10/2015
2	Vomiting 11/2016 - 04/2012
2	Anemia 01/2013 - 04/2012
2	Breast Neoplasms (Breast Cancer) 01/2010 - 10/2009
1	Pain (Aches) 01/2023
1	Tics (Tic) 01/2023
1	Atherosclerosis 08/2022
1	Atherosclerotic Plaque (Atheroma) 08/2022
1	Neuroendocrine Carcinoma 08/2022

Drug/Important Bio-Agent (IBA)

32	PlatinumIBA 01/2024 - 08/2008
13	Carboplatin (JM8)FDA LinkGeneric 10/2022 - 08/2007
12	Protein Glutamine gamma Glutamyltransferase 2IBA 01/2022 - 08/2007
8	EnzymesIBA 10/2022 - 09/2006
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2007
7	LipidsIBA 01/2024 - 01/2017
7	Cisplatin (Platino)FDA LinkGeneric 01/2024 - 06/2008
7	Paclitaxel (Taxol)FDA LinkGeneric 10/2022 - 08/2007
7	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2007
6	RNA (Ribonucleic Acid)IBA 01/2024 - 06/2014
6	guadecitabineIBA 01/2020 - 09/2014
6	olaparibIBA 10/2018 - 04/2012
5	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 09/2014
5	Transcription Factors (Transcription Factor)IBA 01/2023 - 12/2014
5	Small Interfering RNA (siRNA)IBA 01/2023 - 01/2016
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2024 - 12/2007
4	Aldehyde DehydrogenaseIBA 01/2023 - 09/2014
4	CateninsIBA 01/2023 - 08/2013
4	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 10/2009
4	MicroRNAs (MicroRNA)IBA 01/2022 - 05/2011
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018 - 07/2014
4	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 08/2008 - 01/2004
3	CholesterolIBA 01/2024 - 10/2009
3	MethyltransferasesIBA 01/2023 - 01/2018
3	Triglycerides (Triacylglycerol)IBA 05/2022 - 02/2013
3	IntegrinsIBA 01/2018 - 09/2002
3	Decitabine FDA Link 01/2015 - 05/2012
3	Bevacizumab (Avastin)FDA Link 12/2014 - 07/2012
3	Messenger RNA (mRNA)IBA 06/2009 - 09/2002
3	Imatinib Mesylate (Gleevec)FDA Link 08/2008 - 01/2004
2	Alpha-Ketoglutarate-Dependent Dioxygenase FTOIBA 01/2023 - 01/2020
2	N-methyladenosineIBA 01/2023 - 01/2020
2	6-methyladenineIBA 01/2023 - 01/2020
2	Uric Acid (Urate)IBA 11/2022 - 11/2022
2	Fatty Acids (Saturated Fatty Acids)IBA 10/2022 - 01/2022
2	pembrolizumabIBA 10/2022 - 01/2019
2	InterferonsIBA 01/2021 - 01/2019
2	LigandsIBA 01/2019 - 09/2002
2	CytokinesIBA 12/2018 - 05/2012
2	Fibronectins (Fibronectin)IBA 01/2018 - 08/2007
2	liposomal doxorubicin (Doxil)FDA Link 02/2014 - 06/2009
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2013 - 01/2013
2	Phosphotransferases (Kinase)IBA 01/2013 - 01/2007
2	KCC 009IBA 06/2009 - 10/2008
2	Platelet-Derived Growth Factor alpha ReceptorIBA 01/2007 - 01/2004
1	Phospholipid Hydroperoxide Glutathione PeroxidaseIBA 01/2024
1	Benzo(a)pyreneIBA 08/2023
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2023
1	EndocannabinoidsIBA 01/2023
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023
1	Histone MethyltransferasesIBA 01/2023
1	Urea (Carbamide)FDA LinkGeneric 11/2022
1	Indicators and Reagents (Reagents)IBA 11/2022
1	Malondialdehyde (Propanedial)IBA 11/2022
1	Environmental Pollutants (Pollutants, Environmental)IBA 11/2022
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 11/2022
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2022
1	NivolumabIBA 08/2022

Therapy/Procedure

29	Drug Therapy (Chemotherapy) 01/2024 - 08/2007
27	Therapeutics 01/2024 - 06/2009
3	Immunotherapy 08/2022 - 11/2019
3	Aftercare (After-Treatment) 01/2022 - 01/2018
3	Radiotherapy 01/2019 - 09/2015
2	Chemoradiotherapy 01/2022 - 01/2019
2	Vagus Nerve Stimulation 01/2020 - 01/2019
2	Adjuvant Chemotherapy 01/2019 - 01/2019
2	Brachytherapy 01/2019 - 09/2015